Use Of AI To Treat COVID-19 Shows Novel Inventorship Issues

Reprinted from: Law360 | Apr 13, 2020

Technology and medical companies around the world are rising to meet the challenges created by the COVID-19 pandemic, in many cases turning to artificial intelligence (AI) and super computers to develop life-saving treatments for the disease as quickly as possible. While the use of AI will undoubtedly bring tremendous innovation, the data, test results and any inventions resulting from its use will also raise questions about how to best protect these innovations and who should get credit as an inventor.

Read "Use Of AI To Treat COVID-19 Shows Novel Inventorship Issues." (Law360 subscription required)

CadwaladerNews

CadwaladerSpotlight

Making a Mark on Our Communities: Pro Bono Report 2020

Cadwalader's research and intelligence platform provides analysis on changes in U.S. financial regulation. Subscribers receive a daily newsletter interpreting new laws, rules and enforcement actions that impact financial institutions.